France· FR:67941295
CEFUROXIME PANPHARMA 750 mg, poudre pour solution injectable (IM-IV)
A medicinal product containing céfuroxime sodique, registered in France by PANPHARMA.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CÉFUROXIME SODIQUE
- Manufacturer
- PANPHARMA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093574842310 flacon(s) en verre de 789 mg
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Céfuroxime sodique in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsCefuroxim Fresenius Kabi 750 mg, poeder voor oplossing voor injectie/infusieFresenius Kabi Nederland B.V.
- PolandAprokamLaboratoires Thea
- United KingdomAprokam 50mg powder for solution for injection vialsThea Pharmaceuticals Ltd
- SpainCEFUROXIMA ALTER 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Alter S.A.
- FinlandAprokamLaboratoires Thea
- SwitzerlandAprokam, poudre pour solution injectableTHEA Pharma S.A.
- CzechiaAPROKAMLaboratoires Thea, Clermont-Ferrand
- GermanyAprokamLaboratoires Thea
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aprokam, Cefuroxim Aptapharma
- Belgium · Aprokam, Cefuroxim Fresenius Kabi
- Bulgaria · Аксетин, Аксеф
- Cyprus · Axetine, Cefurax
- Czechia · Aprokam, Axetine
- Germany · Aprokam, Cefurax
- Denmark · Aprokam, Cefuroxim B. Braun
- Estonia · Axetine, Cefuroxime Mip
- Spain · Cefuroxima Alter, Cefuroxima Cinfa
- Finland · Aprokam, Cefirion
- United Kingdom (Northern Ireland) · Aprokam, Cefuroxime
- Greece · Anaptivan, Cefur
- Croatia · Axetine, Beloxim
- Hungary · Cefuroxim Kabi, Cefuroxime Aptapharma
- Ireland · Aprok, Ceftal
- Iceland · Aprokam, Cefuroxim Fresenius Kabi
- Italy · Aprokam, Cefuroxima K24 Pharmaceuticals
- Lithuania · Axetine, Cefuroxime Mip
- Luxembourg · Aprokam, Cefuroxim Fresenius
- Latvia · Axetine, Cefuroxime Bcpp
- Malta · Axetine, Cefuroxime Axetil Ccav
- Netherlands · Aprokam, Cefuroxim Fresenius Kabi
- Norway · Aprokam, Cefuroxim B. Braun
- Poland · Aprokam, Biofuroksym
- Portugal · Antibioxime, Aprokam
- Romania · Aprokam, Axetine
- Sweden · Aprokam, Cefuroxim Mip
- Slovenia · Aprokam, Cefuroksim Aptapharma
- Slovakia · Aprokam, Axetine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afd64767-0ae6-4444-9668-df7bd4542f72 GET /v1/drugs/afd64767-0ae6-4444-9668-df7bd4542f72?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67941295",
"date_amm": "1998-02-24",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CÉFUROXIME SODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution injectable",
"voies_administration": "intramusculaire;intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about céfuroxime sodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.